Bob Wildin is the clinical and laboratory geneticist leading Vermonts healthcare-integrated Genomic Population Health testing program. The test sequences more than 400 genes in adults with any health status and has identified personal genetic health risks in up to one third of unselected adults and recessive carrier status in more than 85%. Dr. Wildin also attends on the Clinical Genetics service, interprets clinical somatic tumor NGS testing, teaches genetics across the medical education spectrum, and serves on an FDA Data Safety Monitoring Committee for a gene therapy trial. Dr. Wildin has practiced and done human genetics research in multiple US locations as well as in Paris, France. Dr. Wildin is passionate about closing the gaps. Before coming to Vermont, Dr. Wildin served as Chief of the Genomic Healthcare Branch at the National Human Genome Research Institute at NIH, where he promoted the integration of advances in genomic science into mainstream medical practice.
Sharon Terry, Genetic Alliance & Alice Rathjen